The global Adult Vaccines Market Growth Accelerated by Increasing Burden of Preventable Diseases
Adult vaccines help prevent various infectious diseases and are increasingly being adopted to provide protection against diseases like pneumonia, shingles, hepatitis, and tetanus. Adult vaccines are designed to boost immunity in adults against potentially fatal yet preventable diseases. With growing awareness about benefits of adult vaccination and rising prevalence of diseases, healthcare experts recommend periodic booster doses throughout adulthood.
The global Adult
Vaccines Market is estimated to be valued at US$ 16,790.11 Mn in 2023 and
is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing burden of adult preventable diseases is the primary factor
fueling the demand for adult vaccines. As per CDC, around 50,000 adults in the
U.S. are hospitalized due to pneumonia each year, despite availability of
preventive treatment. With rising healthcare costs of disease treatment, adult
vaccinations are being increasingly adopted for their protective benefits.
Manufacturers are also focusing on development of new multivalent vaccines
providing immunity against multiple serotypes of a virus or bacterium. This is
expected to further boost the adult vaccination uptake over the forecast
period.
Segment
Analysis
The global adult vaccines market is dominated by the influenza vaccines
sub-segment. Influenza causes significant morbidity and mortality worldwide
every year. It imposes heavy burden on healthcare systems. Owing to this,
influenza vaccines segment holds the major share as most adults are recommended
to receive annual flu vaccination. Furthermore, the high efficiency and
efficacy of influenza vaccines compared to other types also contributes to its
market dominance.
Key Takeaways
The global adult vaccines market is expected to witness high growth over the
forecast period of 2023 to 2030. The market is projected to grow at a CAGR of
7.1% during this period and reach a size of US$ 16,790.11 Mn by 2023.
Regional analysis
Key players
Key players operating in the adult vaccines market are GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc. GlaxoSmithKline Plc and Sanofi Pasteur currently dominate the global adult vaccines market due to their extensive influenza vaccine product portfolio and strong global distribution channels.
Comments
Post a Comment